The FDA approval process for new cancer treatments typically involves several phases. After preclinical testing in the laboratory and on animals, a treatment must go through three phases of clinical trials in humans. These phases assess the treatment's safety, efficacy, and optimal dosages. If the treatment successfully passes these trials, the researchers can submit a New Drug Application (NDA) to the FDA for approval.
